UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001769
Receipt number R000002100
Scientific Title Study of usefulness of the demarcation line in magnified endoscopy-combined narrow band imaging (NBI) for determining the expanded area of early-stage differentiated gastric carcinoma
Date of disclosure of the study information 2009/03/12
Last modified on 2012/09/12 19:08:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of usefulness of the demarcation line in magnified endoscopy-combined narrow band imaging (NBI) for determining the expanded area of early-stage differentiated gastric carcinoma

Acronym

NBI study for early-stage gastric carcinoma

Scientific Title

Study of usefulness of the demarcation line in magnified endoscopy-combined narrow band imaging (NBI) for determining the expanded area of early-stage differentiated gastric carcinoma

Scientific Title:Acronym

NBI study for early-stage gastric carcinoma

Region

Japan


Condition

Condition

Gastric cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To estimate the usefulness of the demarcation line in magnified endoscopy-combined narrow band imaging (NBI) for determining the expanded area of early-stage differentiated gastric carcinoma

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Diagnostic accuracy

Key secondary outcomes

(1)The rate of consistency of the boundary between the cancerous and non-cancerous mucosa(Demarcation Line) on magnified NBI and that identified in the biopsied speciment
(2)Sensitivity and specificity


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(a)differenciated gastric carcinoma of the superficial depressed or flat types as determined at standard endoscopy
(b)Written informed consent
(c)20<= age

Key exclusion criteria

(a)Protruded and superficial elevated types
(b)Undifferenciated gastric carcinoma
(c)The lesions with ulceration
(d)Sever concomitant disease
(e)Poor condition to obtain appropriate endoscopic images
(f)Any other inappropriate condition for participating this study estimated by physician

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroto Kita

Organization

Saitama Medical University International Medical Center

Division name

Division of Gastroenterology

Zip code


Address

1397-1 Yamane Hidakashi Saitama, 350-1298, Japan

TEL

042-984-0053

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kouichi Nonaka

Organization

Saitama Medical University International Medical Center

Division name

Division of Gastroenterology

Zip code


Address

1397-1 Yamane Hidakashi Saitama, 350-1298, Japan

TEL

042-984-0053

Homepage URL


Email

nonaka@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University International Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

None


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 03 Month 12 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 03 Month 12 Day

Date of IRB


Anticipated trial start date

2009 Year 03 Month 01 Day

Last follow-up date

2010 Year 03 Month 01 Day

Date of closure to data entry

2010 Year 03 Month 01 Day

Date trial data considered complete

2010 Year 03 Month 01 Day

Date analysis concluded

2010 Year 03 Month 01 Day


Other

Other related information

prospective study


Management information

Registered date

2009 Year 03 Month 12 Day

Last modified on

2012 Year 09 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002100


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name